4//SEC Filing
Epstein David M. 4
Accession 0000899243-20-034186
CIK 0001701541other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 7:39 PM ET
Size
11.7 KB
Accession
0000899243-20-034186
Insider Transaction Report
Form 4
Epstein David M.
DirectorSee Remarks
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2020-12-15−2,500→ 233,116 totalExercise: $6.42Exp: 2029-08-13→ Common Stock (2,500 underlying) - Exercise/Conversion
Common Stock
2020-12-15$6.42/sh+2,500$16,050→ 705,423 total
Holdings
- 16,579(indirect: See footnote)
Common Stock
- 16,579(indirect: See footnote)
Common Stock
- 23,090(indirect: See footnote)
Common Stock
- 104,449(indirect: See footnote)
Common Stock
- 104,449(indirect: See footnote)
Common Stock
Footnotes (6)
- [F1]Shares held by wife.
- [F2]Shares held by David M. Epstein 2019 Trust For Elle. David M. Epstein is the trustee of the David M. Epstein 2019 Trust for Elle and may be deemed to beneficially own these securities.
- [F3]Shares held by David M. Epstein 2019 Trust For Zoe. David M. Epstein is the trustee of the David M. Epstein 2019 Trust for Zoe and may be deemed to beneficially own these securities.
- [F4]Shares held by David M. Epstein 2019 Trust For Robert. David M. Epstein is the trustee of the David M. Epstein 2019 Trust for Robert and may be deemed to beneficially own these securities.
- [F5]Shares held by David M. Epstein 2019 Trust For Shelley. David M. Epstein is the trustee of the David M. Epstein 2019 Trust for Shelley and may be deemed to beneficially own these securities.
- [F6]25% of the shares subject to this option vested and became exercisable on August 14, 2020, with the remainder vesting in 36 equal monthly installments thereafter.
Documents
Issuer
Black Diamond Therapeutics, Inc.
CIK 0001701541
Entity typeother
Related Parties
1- filerCIK 0001488668
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 7:39 PM ET
- Size
- 11.7 KB